INTRODUCTION: While progressive MRI brain changes characterize advanced Parkinson's disease (PD), little has been discovered about structural alterations in the earliest phase of the disease, i.e. in patients with motor symptoms and with normal cognition. Our study aimed to detect grey matter (GM) and white matter (WM) changes in PD patients without cognitive impairment. METHODS: Twenty PD patients and twenty-one healthy controls (HC) were tested for attention, executive function, working memory, and visuospatial and language domains. High-resolution T1-weighted and 60 directional diffusion-weighted 3T MRI images were acquired. The cortical, deep GM and WM volumes and density, as well as the diffusion properties of WM, were calculated. Analyses were repeated on data flipped to the side of the disease origin. RESULTS: PD patients did not show any significant differences from HC in cognitive functioning or in brain volumes. Decreased GM intensity was found in the left superior parietal lobe in the right (p<0.02) and left (p<0.01) flipped data. The analysis of original, un-flipped data demonstrated elevated axial diffusivity (p<0.01) in the superior and anterior corona radiata, internal capsule, and external capsule in the left hemisphere of PD relative to HC, while higher mean and radial diffusivity were discovered in the right (p<0.02 and p<0.03, respectively) and left (p<0.02 and p<0.02, respectively) in the fronto-temporal WM utilizing flipped data. CONCLUSIONS: PD patients without cognitive impairment and GM atrophy demonstrated widespread alterations of WM microstructure. Thus, WM impairment in PD might be a sensitive sign preceding the neuronal loss in associated GM regions.

Central European Institute of Technology Masaryk University Neuroscience Centre Brno Czech Republic

Department of Imaging School of Medicine Masaryk University and St Anne's University Hospital Brno Czech Republic

Department of Neurology Albert Szent Györgyi Clinical Center University of Szeged Szeged Hungary

Department of Pediatrics University of Minnesota Minneapolis Minnesota United States of America

Movement Disorders Center; 1st Department of Neurology School of Medicine Masaryk University and St Anne's University Hospital Brno Czech Republic

Zobrazit více v PubMed

Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G, Norwegian ParkWest Study G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology. 2009;72(13):1121–6. doi: 10.1212/01.wnl.0000338632.00552.cb . PubMed DOI

Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson’s disease: a cohort study. The Lancet Neurology. 2016. doi: 10.1016/S1474-4422(16)30328-3 . PubMed DOI PMC

Chen L, Yu C, Zhang N, Liu J, Liu W. Cognitive impairment in patients with Parkinson’s disease: A 30-month follow-up study. Clinical Neurology and Neurosurgery. 2016;151:65–9. doi: 10.1016/j.clineuro.2016.09.021 . PubMed DOI

Mak E, Su L, Williams GB, O′Brien JT. Neuroimaging correlates of cognitive impairment and dementia in Parkinson’s disease. Parkinsonism & Related Disorders. 2015;21(8):862–70. doi: 10.1016/j.parkreldis.2015.05.013 . PubMed DOI

Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, et al. White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurology. 2013;80(20):1841–9. doi: 10.1212/WNL.0b013e3182929f62 . PubMed DOI

Hattori T, Orimo S, Aoki S, Ito K, Abe O, Amano A, et al. Cognitive status correlates with white matter alteration in Parkinson’s disease. Human Brain Mapping. 2012;33(3):727–39. doi: 10.1002/hbm.21245 . PubMed DOI PMC

Auning E, Kjaervik VK, Selnes P, Aarsland D, Haram A, Bjornerud A, et al. White matter integrity and cognition in Parkinson’s disease: a cross-sectional study. BMJ open. 2014;4(1):e003976 doi: 10.1136/bmjopen-2013-003976 . PubMed DOI PMC

Sterling NW, Du G, Lewis MM, Swavely S, Kong L, Styner M, et al. Cortical gray and subcortical white matter associations in Parkinson’s disease. Neurobiology of Aging. 2016;49:100–8. doi: 10.1016/j.neurobiolaging.2016.09.015 . PubMed DOI PMC

Agosta F, Canu E, Stojkovic T, Pievani M, Tomic A, Sarro L, et al. The topography of brain damage at different stages of Parkinson’s disease. Human Brain Mapping. 2013;34(11):2798–807. doi: 10.1002/hbm.22101 . PubMed DOI PMC

Zhang J, Zhang YT, Hu WD, Li L, Liu GY, Bai YP. Gray matter atrophy in patients with Parkinson’s disease and those with mild cognitive impairment: a voxel-based morphometry study. International Journal of Clinical and Experimental Medicine. 2015;8(9):15383–92. . PubMed PMC

Chen FX, Kang DZ, Chen FY, Liu Y, Wu G, Li X, et al. Gray matter atrophy associated with mild cognitive impairment in Parkinson’s disease. Neuroscience Letters. 2016;617:160–5. doi: 10.1016/j.neulet.2015.12.055 . PubMed DOI

Schneider CB, Donix M, Linse K, Werner A, Fauser M, Klingelhoefer L, et al. Accelerated Age-Dependent Hippocampal Volume Loss in Parkinson Disease With Mild Cognitive Impairment. American Journal of Alzheimer’s Disease and Other Dementias. 2017:1533317517698794 doi: 10.1177/1533317517698794 . PubMed DOI PMC

Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Archives of Neurology. 2011;68(12):1562–8. doi: 10.1001/archneurol.2011.725 . PubMed DOI PMC

Lee JE, Park B, Song SK, Sohn YH, Park HJ, Lee PH. A comparison of gray and white matter density in patients with Parkinson’s disease dementia and dementia with Lewy bodies using voxel-based morphometry. Movement Disorders: Official Journal of the Movement Disorder Society. 2010;25(1):28–34. doi: 10.1002/mds.22858 . PubMed DOI

Agosta F, Pievani M, Sala S, Geroldi C, Galluzzi S, Frisoni GB, et al. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology. 2011;258(3):853–63. doi: 10.1148/radiol.10101284 . PubMed DOI

Pierpaoli C, Barnett A, Pajevic S, Chen R, Penix LR, Virta A, et al. Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. NeuroImage. 2001;13(6 Pt 1):1174–85. doi: 10.1006/nimg.2001.0765 . PubMed DOI

Alexander AL, Hurley SA, Samsonov AA, Adluru N, Hosseinbor AP, Mossahebi P, et al. Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains. Brain Connectivity. 2011;1(6):423–46. doi: 10.1089/brain.2011.0071 . PubMed DOI PMC

Szabo N, Kincses ZT, Pardutz A, Toth E, Szok D, Csete G, et al. White matter disintegration in cluster headache. The Journal of Headache and Pain. 2013;14:64 doi: 10.1186/1129-2377-14-64 . PubMed DOI PMC

Kiraly A, Szabo N, Pardutz A, Toth E, Tajti J, Csete G, et al. Macro- and microstructural alterations of the subcortical structures in episodic cluster headache. Cephalalgia: an International Journal of Headache. 2017:333102417703762 doi: 10.1177/0333102417703762 . PubMed DOI

Koelkebeck K, Miyata J, Kubota M, Kohl W, Son S, Fukuyama H, et al. The contribution of cortical thickness and surface area to gray matter asymmetries in the healthy human brain. Human Brain Mapping. 2014;35(12):6011–22. doi: 10.1002/hbm.22601 . PubMed DOI PMC

Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Medical Image Analysis. 2001;5(2):143–56. . PubMed

Smith SM. Fast robust automated brain extraction. Human Brain Mapping. 2002;17(3):143–55. doi: 10.1002/hbm.10062 . PubMed DOI PMC

Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage. 2004;23 Suppl 1:S208–19. Epub 2004/10/27. doi: 10.1016/j.neuroimage.2004.07.051 . PubMed DOI

Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage. 2006;31(4):1487–505. doi: 10.1016/j.neuroimage.2006.02.024 . PubMed DOI

Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage. 2009;44(1):83–98. doi: 10.1016/j.neuroimage.2008.03.061 . PubMed DOI

Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage. 2002;17(1):479–89. . PubMed

Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Transactions on Medical Imaging. 2001;20(1):45–57. doi: 10.1109/42.906424 . PubMed DOI

Ashburner J, Friston KJ. Voxel-based morphometry—the methods. NeuroImage. 2000;11(6 Pt 1):805–21. doi: 10.1006/nimg.2000.0582 . PubMed DOI

Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage. 2002;17(2):825–41. . PubMed

Andersson JLR, Jenkinson M, Smith S. Non-linear optimisation FMRIB Technical Report. Oxford: 2007.

Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage. 2011;56(3):907–22. doi: 10.1016/j.neuroimage.2011.02.046 . PubMed DOI PMC

Claassen DO, McDonell KE, Donahue M, Rawal S, Wylie SA, Neimat JS, et al. Cortical asymmetry in Parkinson’s disease: early susceptibility of the left hemisphere. Brain and Behavior. 2016;6(12):e00573 doi: 10.1002/brb3.573 . PubMed DOI PMC

Caminiti SP, Presotto L, Baroncini D, Garibotto V, Moresco RM, Gianolli L, et al. Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson’s disease. NeuroImage Clinical. 2017;14:734–40. doi: 10.1016/j.nicl.2017.03.011 . PubMed DOI PMC

Rektorova I, Biundo R, Marecek R, Weis L, Aarsland D, Antonini A. Grey matter changes in cognitively impaired Parkinson’s disease patients. PloS One. 2014;9(1):e85595 doi: 10.1371/journal.pone.0085595 . PubMed DOI PMC

Vandenberghe R, Molenberghs P, Gillebert CR. Spatial attention deficits in humans: the critical role of superior compared to inferior parietal lesions. Neuropsychologia. 2012;50(6):1092–103. doi: 10.1016/j.neuropsychologia.2011.12.016 . PubMed DOI

Zhang K, Yu C, Zhang Y, Wu X, Zhu C, Chan P, et al. Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson’s disease. European Journal of Radiology. 2011;77(2):269–73. doi: 10.1016/j.ejrad.2009.07.032 . PubMed DOI

Ibarretxe-Bilbao N, Junque C, Segura B, Baggio HC, Marti MJ, Valldeoriola F, et al. Progression of cortical thinning in early Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2012;27(14):1746–53. doi: 10.1002/mds.25240 . PubMed DOI

Filoteo JV, Reed JD, Litvan I, Harrington DL. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2014;29(3):360–7. doi: 10.1002/mds.25633 . PubMed DOI PMC

Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junque C, Bargallo N, et al. Assessment of cortical degeneration in patients with Parkinson’s disease by voxel-based morphometry, cortical folding, and cortical thickness. Human Brain Mapping. 2012;33(11):2521–34. doi: 10.1002/hbm.21378 . PubMed DOI PMC

Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, et al. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study. Brain: a Journal of Neurology. 2015;138(Pt 10):2974–86. doi: 10.1093/brain/awv211 . PubMed DOI PMC

Dalaker TO, Zivadinov R, Larsen JP, Beyer MK, Cox JL, Alves G, et al. Gray matter correlations of cognition in incident Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2010;25(5):629–33. doi: 10.1002/mds.22867 . PubMed DOI

Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, et al. Grey matter atrophy in cognitively impaired Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2012;83(2):188–94. doi: 10.1136/jnnp-2011-300828 . PubMed DOI

Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, et al. Cortical thinning is associated with disease stages and dementia in Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2013;84(8):875–81. doi: 10.1136/jnnp-2012-304126 . PubMed DOI PMC

Peran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, et al. Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain: a Journal of Neurology. 2010;133(11):3423–33. doi: 10.1093/brain/awq212 . PubMed DOI

Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, Voigt K, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson’s syndrome from multiple system atrophy and progressive supranuclear palsy. Annals of Neurology. 1999;45(1):65–74. . PubMed

Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, et al. Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain: a Journal of Neurology. 2002;125(Pt 4):789–800. . PubMed

Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. Journal of Neurology, Neurosurgery, and Psychiatry. 2002;73(5):517–23. doi: 10.1136/jnnp.73.5.517 . PubMed DOI PMC

Messina D, Cerasa A, Condino F, Arabia G, Novellino F, Nicoletti G, et al. Patterns of brain atrophy in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy. Parkisnonism & Related Disorders. 2011;17(3):172–6. doi: 10.1016/j.parkreldis.2010.12.010 PubMed DOI

Lee SH, Kim SS, Tae WS, Lee SY, Choi JW, Koh SB, et al. Regional volume analysis of the Parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus. AJNR American Journal of Neuroradiology. 2011;32(4):682–7. doi: 10.3174/ajnr.A2372 . PubMed DOI PMC

Pitcher TL, Melzer TR, Macaskill MR, Graham CF, Livingston L, Keenan RJ, et al. Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study. Translational Neurodegeneration. 2012;1(1):17 doi: 10.1186/2047-9158-1-17 . PubMed DOI PMC

Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson’s disease. Journal of Neurology. 2006;253(1):26–32. doi: 10.1007/s00415-005-0914-9 . PubMed DOI

Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, Osio M, et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR American Journal of Neuroradiology. 2009;30(6):1222–6. doi: 10.3174/ajnr.A1556 . PubMed DOI PMC

Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P. Altered diffusion in the frontal lobe in Parkinson disease. AJNR American Journal of Neuroradiology. 2008;29(3):501–5. doi: 10.3174/ajnr.A0850 . PubMed DOI PMC

Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB. White matter pathology in Parkinson’s disease: the effect of imaging protocol differences and relevance to executive function. NeuroImage. 2012;62(3):1675–84. doi: 10.1016/j.neuroimage.2012.06.012 . PubMed DOI PMC

Theilmann RJ, Reed JD, Song DD, Huang MX, Lee RR, Litvan I, et al. White-matter changes correlate with cognitive functioning in Parkinson’s disease. Frontiers in Neurology. 2013;4:37 doi: 10.3389/fneur.2013.00037 . PubMed DOI PMC

Zhan W, Kang GA, Glass GA, Zhang Y, Shirley C, Millin R, et al. Regional alterations of brain microstructure in Parkinson’s disease using diffusion tensor imaging. Movement Disorders: Official Journal of the Movement Disorder Society. 2012;27(1):90–7. doi: 10.1002/mds.23917 . PubMed DOI PMC

Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Brooks DJ, Barker RA, et al. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson’s disease? Movement Disorders: Official Journal of the Movement Disorder Society. 2016;31(1):103–10. doi: 10.1002/mds.26312 . PubMed DOI

Canu E, Agosta F, Sarasso E, Volonte MA, Basaia S, Stojkovic T, et al. Brain structural and functional connectivity in Parkinson’s disease with freezing of gait. Human Brain Mapping. 2015;36(12):5064–78. doi: 10.1002/hbm.22994 . PubMed DOI PMC

Bertrand JA, Bedetti C, Postuma RB, Monchi O, Genier Marchand D, Jubault T, et al. Color discrimination deficits in Parkinson’s disease are related to cognitive impairment and white-matter alterations. Movement Disorders: Official Journal of the Movement Disorder Society. 2012;27(14):1781–8. doi: 10.1002/mds.25272 . PubMed DOI

Georgiopoulos C, Warntjes M, Dizdar N, Zachrisson H, Engstrom M, Haller S, et al. Olfactory Impairment in Parkinson’s Disease Studied with Diffusion Tensor and Magnetization Transfer Imaging. Journal of Parkinson’s disease. 2017;7(2):301–11. doi: 10.3233/JPD-161060 . PubMed DOI PMC

Mishra V. S K, Zhuang X, Yang Z, Bird C, Cordes D, Walsh R. Voxelwise differences in white matter of early Parkinson’s disease (PD) subjects. OHBM; Vencouver, Canada: 2017.

Budde MD, Xie M, Cross AH, Song SK. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2009;29(9):2805–13. doi: 10.1523/JNEUROSCI.4605-08.2009 . PubMed DOI PMC

Teismann P, Schulz JB. Cellular pathology of Parkinson’s disease: astrocytes, microglia and inflammation. Cell and Tissue Research. 2004;318(1):149–61. doi: 10.1007/s00441-004-0944-0 . PubMed DOI

Zhang J, Aggarwal M, Mori S. Structural insights into the rodent CNS via diffusion tensor imaging. Trends in Neurosciences. 2012;35(7):412–21. doi: 10.1016/j.tins.2012.04.010 . PubMed DOI PMC

Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor imaging of the brain. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. 2007;4(3):316–29. doi: 10.1016/j.nurt.2007.05.011 . PubMed DOI PMC

Picconi B, Piccoli G, Calabresi P. Synaptic dysfunction in Parkinson’s disease. Advances in Experimental Medicine and Biology. 2012;970:553–72. doi: 10.1007/978-3-7091-0932-8_24 . PubMed DOI

Tessitore A, Giordano A, Russo A, Tedeschi G. Structural connectivity in Parkinson’s disease. Parkinsonism & Related Disorders. 2016;22 Suppl 1:S56–9. doi: 10.1016/j.parkreldis.2015.09.018 . PubMed DOI

Braak H, Sandmann-Keil D, Gai W, Braak E. Extensive axonal Lewy neurites in Parkinson’s disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neuroscience Letters. 1999;265(1):67–9. . PubMed

Tessitore A, Esposito F, Vitale C, Santangelo G, Amboni M, Russo A, et al. Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology. 2012;79(23):2226–32. doi: 10.1212/WNL.0b013e31827689d6 . PubMed DOI

Rektor I, Goldemund D, Bednarik P, Sheardova K, Michalkova Z, Telecka S, et al. Impairment of brain vessels may contribute to mortality in patients with Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2012;27(9):1169–72. doi: 10.1002/mds.25066 . PubMed DOI

Vesely B, Antonini A, Rektor I. The contribution of white matter lesions to Parkinson’s disease motor and gait symptoms: a critical review of the literature. Journal of Neural Transmission. 2016;123(3):241–50. doi: 10.1007/s00702-015-1470-9 . PubMed DOI

Ham JH, Yun HJ, Sunwoo MK, Hong JY, Lee JM, Sohn YH, et al. Topography of cortical thinning associated with white matter hyperintensities in Parkinson’s disease. Parkinsonism & Related Disorders. 2015;21(4):372–7. doi: 10.1016/j.parkreldis.2015.01.015 . PubMed DOI

Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, et al. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson’s disease. European Journal of Neurology. 2014;21(6):922–e50. doi: 10.1111/ene.12412 . PubMed DOI

Zhang Y, Wu IW, Tosun D, Foster E, Schuff N, Parkinson’s Progression Markers I. Progression of Regional Microstructural Degeneration in Parkinson’s Disease: A Multicenter DiffusionTensorImagingStudy. PloSOne.2016;11(10):e0165540 doi: 10.1371/journal.pone.0165540 . PubMed DOI PMC

Agosta F, Canu E, Stefanova E, Sarro L, Tomic A, Spica V, et al. Mild cognitive impairment in Parkinson’s disease is associated with a distributed pattern of brain white matter damage. Human Brain Mapping. 2014;35(5):1921–9. doi: 10.1002/hbm.22302 . PubMed DOI PMC

Alves GS, Oertel Knochel V, Knochel C, Carvalho AF, Pantel J, Engelhardt E, et al. Integrating retrogenesis theory to Alzheimer’s disease pathology: insight from DTI-TBSS investigation of the white matter microstructural integrity. BioMed Research International. 2015;2015:291658 doi: 10.1155/2015/291658 . PubMed DOI PMC

Dyrby TB, Lundell H, Burke MW, Reislev NL, Paulson OB, Ptito M, et al. Interpolation of diffusion weighted imaging datasets. NeuroImage. 2014;103:202–13. doi: 10.1016/j.neuroimage.2014.09.005 . PubMed DOI

Smith SM, Johansen-Berg H, Jenkinson M, Rueckert D, Nichols TE, Miller KL, et al. Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nature Protocols. 2007;2(3):499–503. doi: 10.1038/nprot.2007.45 . PubMed DOI

Jones DK, Cercignani M. Twenty-five pitfalls in the analysis of diffusion MRI data. NMR in Biomedicine. 2010;23(7):803–20. doi: 10.1002/nbm.1543 . PubMed DOI